OCULAR THERAPEUTIX, INC
Public company- Headquarters
- BEDFORD, Massachusetts
- Ticker
- OCUL
- CIK
- 0001393434
WARN notices since 2024
Workers affected since 2024
Executive changes, last 12 months
Last event
Workers affected over time
Cumulative workers in WARN notices since 2024
Not enough notices to chart yet.
Leadership
| Role and person | Since | Change |
|---|---|---|
| Chief Strategy OfficerSanjay Nayak, M.B.B.S., Ph.D. | Oct 16, 2026 | Departed |
Related companies
Same industry and state, with recent events.
- ENANTA PHARMACEUTICALS INC
CEO departs: Jay R. Luly, Ph.D.
- VERTEX PHARMACEUTICALS INC / MA
new member of the board of directors appointed: Daniel Brennan
- Ernexa Therapeutics Inc.
member of the Board appointed: Robert J. Spiegel, M.D.
- BRISTOL MYERS SQUIBB CO
WARN notice: Princeton, NJ
- Executive departure
Chief Strategy Officer departs: Sanjay Nayak, M.B.B.S., Ph.D.
Sanjay Nayak, M.B.B.S., Ph.D., Chief Strategy Officer of OCULAR THERAPEUTIX, INC, resigns the role, effective October 16, 2026. The company reported the change in an 8-K that cites Item 5.02.
Source: SEC 8-K, filed Oct 16, 2026Role: Chief Strategy Officer
Only one public record so far. We add events as soon as a new filing lands; watch OCULAR THERAPEUTIX, INC to get them in your digest.
Last verified Nov 8, 2026